Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 01, 2016
Source ID
10.1016/s1470-2045(16)30053-5

Entities

People

  • Alexander Vortmeyer
  • Amanda Ralabate
  • Amit Mahajan
  • Angel Rivera
  • Anne C Chiang
  • Apostolos John Tsiouris
  • Elin Rowen
  • Harriet M Kluger
  • Heather Gerrish
  • James Yu
  • Justine Cohen
  • Lucia Jilaveanu
  • Mario Sznol
  • Matthew Madura
  • Roy S. Herbst
  • Sarah B. Goldberg
  • Scott N. Gettinger
  • Stephanie Speaker
  • Upendra Hegde
  • Veronica Chiang
  • Xiaopan Yao

Organizations

  • Lung Cancer Research Foundation
  • Melanoma Research Alliance
  • National Center for Advancing Translational Sciences
  • National Center for Research Resources
  • National Institutes of Health
  • Office of the Secretary of Defense